by Isabella Backman, Yale University Graphical abstract. Credit: Cell Reports (2022). DOI: 10.1016/j.celrep.2022.110569 In the face of cancer, oncologists face a dual epidemic of overtreatment and undertreatment. Treating the disease often involves harsh chemotherapies and other interventions with extensive side effects. As a result, clinicians might delay treating a growth that looks harmless until it becomes life...
